IdenTrust compliant with SAFE-BioPharma digital signature & ID standards

HID Global's IdenTrust Enterprise Solution has been certified compliant with SAFE-BioPharma Association’s digital identity and signature standards.


https://facilityexecutive.com/2019/03/digital-signature-identity-compliance/
HID Global's IdenTrust Enterprise Solution has been certified compliant with SAFE-BioPharma Association’s digital identity and signature standards.
Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Digital Signature & Identity Compliance

SAFE-BioPharma Association certifies HID Global’s IdenTrust digital certificates as compliant with its digital identity and signature standards

IdenTrust compliant with SAFE-BioPharma digital signature & ID standards

HID Global® announced that its IdenTrust® Enterprise Solution has been certified compliant with SAFE-BioPharma Association’s digital identity and digital signature standards, paving the way for the association’s global member companies to confidently deploy the solution. SAFE-BioPharma Association was created by the biopharmaceutical industry and its regulators, and the standards developed are now used to provide global high-assurance identity trust for cyber-transactions throughout the pharmaceutical and healthcare community.digital signature

Pharmaceutical and healthcare companies can use HID IdenTrust digital certificates to provide digital credentials that improve the user experience, enhance patient safety, and allow for secure access to websites, networks, systems, or applications with strong, two-factor authentication, which is critical for regulatory compliance and countering cyberattacks. The digital certificates also support advanced security use cases, including data encryption and digital signing capabilities.

“We are pleased to have certified our IdenTrust Digital Certificates with SAFE-BioPharma standards.” said Brad Jarvis, Vice President and Managing Director, Identity & Access Management, with HID Global. “With our IdenTrust digital certificates along with our portfolio of HID identity and access management products, we look forward to helping SAFE-BioPharma members and the wider pharmaceutical and healthcare communities to solve challenges they face related to regulatory compliance, end-user authentication, digital signing, interoperability, and data protection.”

HID Global’s IdenTrust digital certificates can be used by pharmaceutical companies and healthcare organizations to secure applications with two-factor authentication, thereby increasing overall information security when compared to more traditional, password-only protection. HID Global’s IdenTrust digital certificates enable digital signing of clinical trial information to regulatory bodies, such as the United States Federal & Drug Administration (FDA).

Additionally, SAFE-BioPharma compliant IdenTrust digital certificates can be used to digitally sign electronic documents to create a legally binding digital signature. This method of creating digital signature(s) is integral to processes and practices in the pharmaceutical and healthcare industry, such as digitally signing ePrescriptions for controlled substances in compliance with Drug Enforcement Agency’s (DEA) rules for creating Electronic Prescriptions of Controlled Substances (EPCS). Of course the same IdenTrust digital certificates can also be used for more traditional uses such as to secure e-mails, strong user authentication, smartcard logon, and data protection both in transit and at rest.

“Knowing who is accessing systems or signing documents is critical in the healthcare industry where the impact of a mistake or malicious action can have serious implications for patient safety or create serious risks to healthcare companies who must protect personal health information,” said Matt King, Director, SAFE-BioPharma Association. “SAFE-BioPharma is pleased that HID Global’s IdenTrust solution is now available to our member companies who can benefit from HID Global’s experience and industry leadership.”

Suggested Links:

LEAVE A REPLY